featured
10-Day Vonoprazan–Amoxicillin Dual Therapy vs Standard Bismuth-Based Quadruple Therapy for the First-Line Eradication of H pylori Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ten-day vonoprazan-amoxicillin dual therapy versus standard fourteen-day Bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: a multicenter randomized clinical trial
Am. J. Gastroenterol 2023 Nov 17;[EPub Ahead of Print], TL Yan, JH Wang, XJ He, YB Zhu, LJ Lu, YJ Wang, ZW Wang, JG Gao, CF Xu, H Ma, SM Luan, L Li, Y ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.